---
annotations:
- type: Pathway Ontology
  value: hemostasis pathway
authors:
- MaintBot
- ReactomeTeam
- Egonw
- Anwesha
- Mkutmon
description: Leukocyte extravasation is a rigorously controlled process that guides
  white cell movement from the vascular lumen to sites of tissue inflammation. The
  powerful adhesive interactions that are required for leukocytes to withstand local
  flow at the vessel wall is a multistep process mediated by different adhesion molecules.
  Platelets adhered to injured vessel walls form strong adhesive substrates for leukocytes.
  For instance, the initial tethering and rolling of leukocytes over the site of injury
  are mediated by reversible binding of selectins to their cognate cell-surface glycoconjugates.<p>
last-edited: 2020-10-09
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1794
- /instance/WP1794
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1794.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Leukocyte extravasation is a rigorously controlled process that guides
    white cell movement from the vascular lumen to sites of tissue inflammation. The
    powerful adhesive interactions that are required for leukocytes to withstand local
    flow at the vessel wall is a multistep process mediated by different adhesion
    molecules. Platelets adhered to injured vessel walls form strong adhesive substrates
    for leukocytes. For instance, the initial tethering and rolling of leukocytes
    over the site of injury are mediated by reversible binding of selectins to their
    cognate cell-surface glycoconjugates.<p>
  keywords:
  - 'TGFB1 '
  - 'CD99L2 '
  - 'Ig kappa chain V-II region FR '
  - 'MIF '
  - PROCR:Protein C
  - CyP60 complexed with
  - CXADR bound to JAML
  - Pre-B Cell Surrogate
  - 'CEACAM1 '
  - 'IGLV2-23(1-?) '
  - 'ESAM '
  - 'IGHV(1-?) '
  - 'Ig heavy chain V-II region NEWM '
  - 'opaI '
  - 'IGLL1 '
  - alphaXbeta2:JAM3
  - 'Ig heavy chain V-III region WEA '
  - 'IGLV8-61(1-?) '
  - 'IGLC2 '
  - TREM1
  - 'IGLC1 '
  - 'Ig lambda chain V-III region SH '
  - 'TNFRSF10A '
  - 'eba-140 '
  - SELE
  - 'Ig heavy chain V-II region WAH '
  - BSG:MCTs
  - ANGPT1:p-5Y,S119-TEK
  - 'SLC7A5 '
  - 'CHEST '
  - FN1 dimer
  - 'Ig kappa chain V-II region Cum '
  - ANGPT1:TEK
  - 'PSG5 '
  - MERTK ligands
  - 'IGLV1-36(1-?) '
  - 'SRC-1 '
  - Monocarboxylate
  - 'thrombin light chain '
  - 'IGLV3-27(1-?) '
  - 'IGLV1-44(1-?) '
  - 'thrombin heavy chain '
  - 'GP6 '
  - 'Ig kappa chain V-III region POM '
  - 'opaF '
  - 'Ig lambda chain V-IV region Hil '
  - TSPAN7
  - PECAM-1:SHIP1
  - ITGA4:ITGB1
  - 'IGKV1-5(23-?) '
  - 'Ig kappa chain V-I region Wes '
  - Basigin:Mannose-carrying cell recognition molecules
  - GTP
  - 'SLC7A10 '
  - protein C
  - p21 RAS:GTP
  - 'Ig heavy chain V-II region MCE '
  - GDP
  - 'PTPN6 '
  - PECAM-1:SHP-1
  - proteins
  - Ligand to TREM-1 on
  - 'IGLV3-12(1-?) '
  - 'ITGA3(33-1051) '
  - p-Y663,Y686-PECAM1
  - Phosphorylated Tie2
  - 'APOB(28-4563) '
  - CD177
  - CD99:CD99L2
  - 'Ig heavy chain V-I region HG3 '
  - 'Ig heavy chain V-II region OU '
  - CD98hc complex
  - 'Mn2+ '
  - 'SELP '
  - Proteoglycans,TGFB1
  - 'PICK1 '
  - BSG dimer
  - 'SELPLG '
  - 'EPCAM '
  - 'VPREB1 '
  - 'Ig lambda chain V-IV region Kern '
  - ATP
  - 'CXADR '
  - p-Y663,Y686-PECAM1(27-?)
  - MERTK
  - LDL
  - 'piiC '
  - SOS1
  - 'IGLC6 '
  - JAM3
  - 'IGLV1-40(1-?) '
  - 'PSG9 '
  - 'ATP1B3 '
  - 'ITGAL '
  - MIF trimer
  - 'JCHAIN '
  - 'ITGAV(31-1048) '
  - 'Ig lambda chain V-VI region AR '
  - PTPN11
  - ANGPT2
  - 'TNFRSF10D '
  - 'Ig kappa chain V-I region AU '
  - 'Ig kappa chain V-II region RPMI 6410 '
  - GRB7
  - fibril
  - MERTK:MERKT ligands
  - F11R dimer
  - TEK
  - ANGPT1
  - ANGPT4:TEK
  - 'PSG3 '
  - 'Ig kappa chain V-I region BAN '
  - 'S-Farn-Me KRAS4B '
  - TSPAN7:PICK1
  - 'CD44 '
  - 'CHOL '
  - membrane
  - Integrin alphaMbeta2
  - 'PTPN11 '
  - PPIA
  - affecting integrin
  - PECAM-1:PLC gamma1
  - 'GRB2-1 '
  - Integrin alpha5beta1
  - HS
  - 'PSG7 '
  - 'AMICA1 '
  - BSG:MMP1(100-469)
  - 'GLG1 '
  - 'CD74 '
  - PI3K
  - 'GTP '
  - 'Ig lambda chain V-I region NEWM '
  - 'FYN '
  - 'SELL '
  - 'IGLV5-45(1-?) '
  - Mn2+
  - alphaMbeta2:JAM3
  - 'ATP1B1 '
  - dimer
  - Collagen type I
  - 'SPN '
  - CD2
  - gamma:FYN:LYN
  - 'opa68 '
  - CD47
  - 'Ig kappa chain V-I region AG '
  - 'YES1 '
  - 'Collagen type I fibril '
  - PROC(200-211)
  - eba-175,ebl1,eba-140
  - 'Ig heavy chain V-III region DOB '
  - 'ITGA5(42-894) '
  - JAM2
  - MIF trimer:CD74
  - '11xCbxE-GAS6(39-691) '
  - 'TEK '
  - 'IGLV4-3(1-?) '
  - oxidized LDL
  - 'INPP5D '
  - GRB2-1
  - 'p-Y663,Y686-PECAM1(27-?) '
  - SHC1
  - ADP
  - CEACAM1,3,5,6
  - 'SHC1 '
  - trimer
  - INPP5D
  - 'opaJ '
  - 'SLC7A9 '
  - 'IGLV7-46(1-?) '
  - TNFRSF10A,B:TNFRSF10D
  - 'S-Farn-Me PalmS NRAS '
  - 'Ig lambda chain V-II region MGC '
  - MMP1(100-469)
  - 'ITGB2 '
  - fibronectin
  - 'Ig heavy chain V-III region BRO '
  - 'ITGB1 '
  - 'Syndecans1-4 '
  - CD48
  - 'CEACAM3 '
  - 'CEACAM6 '
  - 'GYPB '
  - 'TREM1 '
  - 'IGKV3D-20 '
  - 'CD177 '
  - 'Ig lambda chain V-II region NEI '
  - Light Chain
  - 'GYPA '
  - FCAMR:2xIgA:JCHAIN
  - 'Ig lambda chain V-II region BOH '
  - 'BSG '
  - 'PSG11 '
  - 'Ig lambda chain V-III region LOI '
  - p85 bound to Tie2
  - 'Ig lambda chain V-I region NEW '
  - JAM2 dimer
  - 'PSG1 '
  - '8xCbxE-3D-PROC(43-197) '
  - 'Ig kappa chain V-I region Gal '
  - PROCR:Activated
  - 'CEACAM8 '
  - CEACAM1,3,5,6:opa
  - Integrin alphaVbeta3
  - 'IGLV3-16(1-?) '
  - alpha3beta1,
  - CD74 trimer
  - CAV1
  - TNFRSF10D
  - 'CD84 '
  - 'PF4V1(31-104) '
  - 'ITGA6(24-1130) '
  - 'LYN '
  - ANGPT4
  - 'PROC(212-461) '
  - 'opaD '
  - 'Ig heavy chain V-I region EU '
  - 'CEACAM5 '
  - 'FN1(32-2386) '
  - Mannose-carrying
  - Selectins:2xSELPG
  - 'IGLV(23-?) '
  - 'SLC16A3 '
  - 'JAM3 '
  - CD84 dimer
  - activated
  - 'PF4(32-101) '
  - CD99
  - 'IGLV2-11(1-?) '
  - PLCG1
  - complex
  - 'SLC7A8 '
  - 'Ig heavy chain V-III region BUT '
  - 'Ig heavy chain V-III region TRO '
  - Tie2 and Dok-2
  - 'MMP1(100-469) '
  - 'PSG4 '
  - 'Ig lambda chain V region 4A '
  - CXADR
  - 'PROC(200-461) '
  - 'IGLV4-60(1-?) '
  - Grb2 bound to Tie2
  - 'IGLC3 '
  - 'GPC1 '
  - the platelet
  - 'PSG6 '
  - PECAM-1:SHP-2
  - 'PLCG1 '
  - 'IGLV11-55(1-?) '
  - CD48:CD244
  - 'TSPAN7 '
  - 'IGLV2-18(1-?) '
  - CD58
  - 'opa65 '
  - Selectins
  - pTie2 and SHP2
  - 'CAV1 '
  - CD58:CD2
  - 'IgH  heavy chain V-III region VH26 precursor '
  - 'IGHV1-2 '
  - 'GYPC '
  - 'PIK3R2 '
  - 'Ig lambda chain V-IV region Bau '
  - Integrin alphaXbeta2
  - SELPLG
  - 2xANGPT1:TEK
  - alphaLbeta2:F11R
  - 'GRB14 '
  - PECAM1:CD177
  - alpha6beta1
  - OLR1
  - ligand
  - 'IGKV2D-30 '
  - JAM3 dimer
  - GYPA,GYPB,GYPC:eba-175,ebl1,eba-140
  - 'Ig heavy chain V-II region ARH-77 '
  - Basigin:CD98hc
  - TNFRSF10A,TNFRSF10B
  - binding to
  - ANGPT1:p-5Y,S119-TEK:SHC1
  - 'GRB7 '
  - FCAMR
  - 'PL '
  - SIRPs:CD47
  - 'IGLC7 '
  - CD84
  - 'L1CAM '
  - 'CD244 '
  - 'SLC3A2 '
  - 'GDP '
  - Basigin
  - 'TNFRSF10B '
  - 'PSG8 '
  - Transporter Set
  - 'eba-175 '
  - 'PPIA '
  - GPVI:FceRI
  - 'IGLV10-54(1-?) '
  - 'Ligand to TREM-1 on the platelet membrane '
  - p21 RAS:GDP
  - 'IGKC '
  - kinases (SFKs)
  - GYPA,GYPB,GYPC
  - Integrin
  - 'ANGPT4 '
  - with Surrogate
  - 'PIK3CB '
  - 'Ig kappa chain V-I region Daudi '
  - ANGPT2:TEK
  - 'opa66 '
  - 'VPREB3 '
  - 'MERTK '
  - BSG:SPN
  - EPCAM
  - BSG
  - CEACAM heterodimer
  - 'opaB '
  - 'ANGPT1 '
  - 'CD2 '
  - 'Ig kappa chain V-I region HK101 '
  - gamma:FYN:LYN:Collagen type I
  - GRB14
  - 'PROCR '
  - PSGs:Proteoglycan,TGFB1
  - 'THBD '
  - PECAM1
  - Tie2 and Grb14
  - 'op28 '
  - TREM-1 bound to its
  - 'DOK2 '
  - IgM Heavy Chain
  - 'S-Farn-Me-PalmS KRAS4A '
  - PTPN6
  - thrombin:thrombomodulin
  - 'ITGAM '
  - BSG:PPIA
  - JAM2:JAM3
  - 'IGKV2-28 '
  - EPCAM dimer
  - 'Ig lambda chain V-I region HA '
  - 'opaH '
  - 'IGHV7-81(1-?) '
  - opa proteins
  - Tie2:Grb2
  - 'FCAMR '
  - PICK1
  - PSGs
  - SELE ligands
  - 'Ig kappa chain V-I region DEE '
  - PPIL2
  - 'IGHA1 '
  - 'IGLV3-22(1-?) '
  - Neutrophil CEACAMs
  - Src family tyrosine
  - 'LCK '
  - SPN
  - Caveolin-1 bound to
  - 'SOS1 '
  - 'opa67 '
  - 'CD58 '
  - 'opaA '
  - 'SIRPA '
  - alphaVbeta3:PECAM1
  - 'Ig lambda chain V-II region TOG '
  - 'Ig heavy chain V-III region KOL '
  - 'PECAM1 '
  - CD244
  - 'Ig heavy chain V-III region CAM '
  - 'opaK '
  - CD99L2
  - integrin
  - 'OLR1 '
  - 'F11R '
  - 'CD47 '
  - 'SLC16A8 '
  - 'Ig kappa chain V region EV15 '
  - 'IGKV4-1(21-?) '
  - 'IGLV2-33(1-?) '
  - 'SIRPG '
  - 'S-Farn-Me-2xPalmS HRAS '
  - 'SLC16A1 '
  - 'CD99 '
  - 2xSELE ligands:SELE
  - alpha5beta1:FN1
  - 'IGLV5-37(1-?) '
  - 'IGHA2 '
  - 'Ig heavy chain V-III region JON '
  - 'opaE '
  - in Tie2/Akt dimer
  - Immunoglobulin Mu
  - 'Ig kappa chain V-III region VG '
  - Integrin alphaLbeta2
  - '11xCbxE-PROS1 '
  - 'SLC7A11 '
  - 'Ig kappa chain V-III region B6 '
  - 'IGLV4-69(1-?) '
  - 'IGKV1-12 '
  - 'PIK3R1 '
  - AMICA1
  - 'IGKVA18(21-?) '
  - molecules
  - 2xIgA:JCHAIN
  - 'IGLV7-43(1-?) '
  - 'PPIL2 '
  - 'SLC7A7 '
  - Tie2:Grb7 complex
  - 'IGHM '
  - 'p-5Y,S1119-TEK '
  - CD47-binding
  - 'JAM2 '
  - 'ITGA4 '
  - 'ANGPT2 '
  - 'FCER1G '
  - 'CD48 '
  - OLR1 bound to
  - 'PSG2 '
  - BSG:Integrin
  - 'ebl1 '
  - 'TAGs '
  - DOK2
  - 'Ca2+ '
  - F11R
  - 'MAG '
  - 'ITGB3 '
  - 'SELE '
  - alpha4beta1:JAM2:JAM3
  - 'opaC '
  - 'IGLV3-25(1-?) '
  - 'PIK3CA '
  - 'SLC7A6 '
  - SOS-1 bound to
  - PECAM1 dimer
  - 'ATP1B2 '
  - 'ITGAX '
  - CD47-binding SIRPs
  - 'opaG '
  - (MCT)
  - Platelet Factor 4
  - 'Ig lambda chain V-I region VOR '
  - cell recognition
  license: CC0
  name: Cell surface interactions at the vascular wall
seo: CreativeWork
title: Cell surface interactions at the vascular wall
wpid: WP1794
---